This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
$1 buys you full access to ALL of TheStreet's Subscription Services! Learn More

Life Technologies Announces Next-Gen Digital PCR Instrument Designed For Widespread Adoption

Stocks in this article: LIFE

CARLSBAD, Calif., Nov. 7, 2012 /PRNewswire/ -- Life Technologies Corporation (NASDAQ: LIFE) today announces the QuantStudio™ 3D Digital PCR System, a scalable, chip-based instrument that is democratizing this technology for a rapidly growing market. Featuring a simple workflow with minimal hands-on time, the benchtop platform is disruptively priced at $30,000 -- enabling access to a broader community. The system is currently with early access customers and commercial shipments will begin in the first half of 2013.

Designed with a scalable architecture, the QuantStudio™ 3D Digital PCR System's first generation chips enable up to 20,000 data points in a single run -- coverage that satisfies the needs for most digital PCR applications today.  The capacity of future chips will increase exponentially to meet increasing demands of the research community.  

The new platform is the latest addition to a growing line of QuantStudio™ digital qPCR instruments from Life Technologies. It complements the QuantStudio™ 12K Flex Real-Time PCR System, which the company launched earlier this year and provides the highest throughput capability for digital PCR on the market.  

Considered until recently a niche segment, the digital PCR market is expected to grow to nearly $250 million globally by 2016. Researchers worldwide use real-time PCR (polymerase chain reaction) to amplify and quantify nucleic acids. Digital PCR takes researchers beyond the limits of real-time PCR for applications that require absolute quantitation of targeted DNA molecules. Additionally, Life's simple workflow and chip-based platform reduce the risk of sample contamination and loss of DNA normally associated with droplet-based systems. The technology is ideal for accurately detecting rare mutations important in cancer or infectious diseases – the equivalent to finding a needle in a haystack. It is also increasingly used as a mechanism to perform quality control experiments on next generation sequencing libraries.

"The QuantStudio™ 3D Digital PCR System is the latest revolutionary platform from the team that has delivered every market-leading technology in qPCR," says Chris Linthwaite, Head of Genetic Analysis, Life Technologies. "By making this novel platform accessible to all labs, we are enabling the democratization of digital PCR and helping the scientific community expand the utilization of this technology in disease research and applications beyond."

Prior to commercial launch, Life Technologies is making the QuantStudio™ 3D Digital PCR System available to early access users through the Digital PCR Applications Grant Program, which will fund 20 research projects that demonstrate innovative applications for the instrument. Five grand prize winners chosen among the winning proposals will receive a QuantStudio™ 3D Digital PCR System. For details on submitting a proposal, visit www.lifetechnologies.com/dpcrgrant.

Life Technologies will host presentations and a poster session from early access users of the system on Nov. 8 at the American Society of Human Genetics conference (ASHG). For more information on these talks, visit Life's ASHG website. The system will be officially unveiled during Explore Art and Science with Life Technologies, a customer event that will showcase the company's latest solutions from the Ion Torrent and Genetic Analysis divisions at the San Francisco Museum of Modern Art on Nov. 7 from 7-10:30 p.m. For invitations to the event or for more information, visit the Life Technologies booth (# 601) during ASGH.

The QuantStudio™ 3D Digital PCR System is For Research Use Only, not intended for diagnostic purposes.

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,814.94 -2.96 -0.02%
S&P 500 2,067.03 -2.38 -0.12%
NASDAQ 4,758.2520 +3.36 0.07%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs